Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from COPD

Pensioner too scared to turn on gas heating due to cost curls up with dog to stay warm

Lyn Joseph, 76, of Perth, Scotland, suffers from the respiratory condition COPD and relies on a small portable heater and her Yorkshire Terrier to keep warm as she fears turning her gas on

Daily Mirror

How improving COPD treatment in primary care could reduce demand on hospitals and emergency departments

In Ontario, nearly 900,000 people live with chronic obstructive pulmonary disease (COPD). People with this condition account for 24 per cent of hospitalizations, 24 per cent of emergency department visits and 21 per cent of ambulatory care visits.

The Conversation

Edinburgh dad dies "of a broken heart" eight weeks after losing his wife

Robert Japp, known as Bob, acted as his wife Matilda's carer after her Emphysema COPD diagnosis left her unable to leave her Edinburgh home in her final years.

Edinburgh Live

From analysis to the latest developments in health,
read the most diverse news in one place.

More people dying owing to COPD in urban areas: Sudhakar

The India Clean Air Summit has been organised by think-tanks Centre for Air Pollution Studies (CAPS) and the Centre for Study of Science, Technology and Policy (CSTEP)

The Hindu

'North-South health divide' is fuelled by COPD and alcohol problems: Research highlights impact of chronic disease on the North East

A new report shows that four illnesses play a disproportionate role in making the North East the least healthy area of England

Chronicle Live

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

UK lung disease deaths ‘being caused by low pay and damp housing’

More than 1.3 million people in the UK suffer from COPD

The Independent UK

Low pay and damp housing driving UK lung disease deaths, study finds

Researchers say 55% of COPD patients suffering two or more acute attacks a year earn under £20,000, with the poorest five times more likely to die from the condition

The Guardian - UK

Twelfth of July: Warning over impact of smoke from bonfires for people with lung conditions

Those with asthma or COPD could find smoke from bonfires triggers their symptoms.

Belfast Live

Signs and symptoms of lung disease as new awareness campaign launched

Monday marks the start of Love You Lungs week, a campaign to raise awareness of lung health. A lung condition can be permanent but there are treatments to slow down progression.

Edinburgh Live

Listening to asthma and COPD: An AI-powered wearable could monitor respiratory health

A neck patch that monitors respiratory sounds may help manage asthma and chronic obstructive pulmonary disease (COPD) by detecting symptom flareups in real time, without compromising patient privacy.

The Conversation

Save your breath: traditional Kyrgyz dance helps ease chronic lung disease

Exercise to help COPD hospital patients is being rolled out across Kyrgyzstan and to neighbouring countries

The Guardian - UK

Hay fever warning in UK amid high pollen levels this weekend

Charity Asthma and Lung UK is advising people with asthma and COPD to take action

Manchester Evening News

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Record

Obese Scots mum shed whopping seven stone 'with help from beyond the grave'

Mum-of-two Amanda Aitken, 42, piled on the pounds during a heavily medicated battle with the respiratory condition COPD.

ABC News

The world's longest respiratory health study involves thousands of Tasmanians

Back in the early 1960s, researchers were seeing a rise in asthma, and wanted to know why. Years later, they are still following the thousands of participants' lives.

Daily Mirror

Former Today show co-host Jim Hartz passes away at 82 after decades-long career at NBC

Award-winning news anchor and former co-host of the Today show Jim Hartz is understood to have passed away at the age of 82, with the cause said to be the lung condition COPD

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

US Food and Drug Administration

62 stories

Asthma Lung UK

48 stories

Perthshire Advertiser

36 stories

Asthma and Lung UK

33 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.